Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (244)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gultekin, S. H.
Right arrow Articles by Dalmau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gultekin, S. H.
Right arrow Articles by Dalmau, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 7, 1481-1494, July 2000
© 2000 Oxford University Press

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

.

S. Humayun Gultekin1,2, Myrna R. Rosenfeld3,4,**, Raymond Voltz1,*, Joseph Eichen1,**, Jerome B. Posner1,3 and Josep Dalmau1,3,**

1 Department of Neurology and the Cotzias Laboratory of Neuro-Oncology and 2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, 3 Department of Neurology and Neuroscience and 4 Division of Neurosurgery, Weill Medical College of Cornell University, New York, USA

Correspondence to: Josep Dalmau, MD, Department of Neurology, University of Arkansas for Medical Sciences, 4301 W. Markham, Slot 500, Little Rock, AR 72205, USA E-mail: dalmaujosep{at}exchange.uams.edu

Paraneoplastic limbic encephalitis (PLE) is a rare disorder characterized by personality changes, irritability, depression, seizures, memory loss and sometimes dementia. The diagnosis is difficult because clinical markers are often lacking, and symptoms usually precede the diagnosis of cancer or mimic other complications. The frequency of antineuronal antibodies in patients with PLE has not been investigated. We examined the neurological symptoms and the causal tumours in 50 patients with PLE to determine the utility of paraneoplastic antibodies and other tests. The diagnosis of PLE required neuropathological examination or the presence of the four following criteria: (i) a compatible clinical picture; (ii) an interval of <4 years between the development of neurological symptoms and tumour diagnosis; (iii) exclusion of other neuro-oncological complications; and (iv) at least one of the following: CSF with inflammatory changes but negative cytology; MRI demonstrating temporal lobe abnormalities; EEG showing epileptic activity in the temporal lobes. Of 1047 patients with neurological symptoms, whose sera or CSF were examined for paraneoplastic antibodies, 79 had the presumptive diagnosis of limbic encephalitis, dementia, cognitive dysfunction, or confusion. Fifty of these patients fulfilled our criteria for PLE. Pathological confirmation was obtained in 12 patients. The commonly associated neoplasms were of the lung (50%), testis (20%) and breast (8%). Neurological symptoms preceded the cancer diagnosis in 60% of patients (by a median of 3.5 months). Twenty-five of 44 (57%) patients with MRI studies had signal abnormalities in the limbic system. Thirty (60%) patients had antineuronal antibodies (18 anti-Hu, 10 anti-Ta, 2 anti-Ma), and 20 were antibody-negative or had uncharacterized antibodies (n = 4). The combination of symptoms, MRI findings and paraneoplastic antibodies established the diagnosis of PLE in 78% of the patients. Patients with anti-Hu antibodies usually had small-cell lung cancer (94%), multifocal neurological symptoms (78%) and a poor neurological outcome. Patients with anti-Ta (also called anti-Ma2) antibodies were young men with testicular tumours (100%), frequent hypothalamic involvement (70%) and a poor neurological outcome. In the group of patients without anti-Hu or anti-Ta antibodies, the tumour distribution was diverse, with cancer of the lung the most common (36%); 57% had positive MRI. Fifteen of 34 (44%) patients with a median follow-up of 8 months showed neurological improvement. Treatment of the tumour appeared to have more effect on the neurological outcome than the use of immune modulation. Improvement was observed in 38% of anti-Hu patients, 30% of anti-Ta patients and 64% of patients without these antibodies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJ Case ReportsHome page
J. Novy, A. Carota, P. Eggimann, M. Pusztaszeri, A. O Rossetti, and R. Du Pasquier
Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
BMJ Case Reports, August 11, 2009; 2009(aug11_1): bcr1220081363 - bcr1220081363.
[Abstract] [Full Text]


Home page
FocusHome page
F. Meyer, M. Ehrlich, and J. Peteet
Psycho-Oncology: A Review for the General Psychiatrist
Focus, July 1, 2009; 7(3): 317 - 331.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Saiz, J Bruna, P Stourac, M C Vigliani, B Giometto, W Grisold, J Honnorat, D Psimaras, R Voltz, and F Graus
Anti-Hu-associated brainstem encephalitis
J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
U G Schulz, S R Thomas, and W Stewart
A difficult case solved at autopsy: memory loss, behavioural change and seizures
Practical Neurology, April 1, 2009; 9(2): 90 - 95.
[Full Text] [PDF]


Home page
PsychosomaticsHome page
A. R. Foster and J. P. Caplan
Paraneoplastic Limbic Encephalitis
Psychosomatics, March 1, 2009; 50(2): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Markert, A. May, J. Weber, C. Rottenburger, S. Rauer, and H. Veelken
Bilateral Renal Lymphoma After Paraneoplastic Limbic Encephalitis
J. Clin. Oncol., March 1, 2009; 27(7): 1142 - 1144.
[Full Text] [PDF]


Home page
NeurologyHome page
J. Wagner, C. Schankin, T. Birnbaum, G. Popperl, and A. Straube
OCULAR MOTOR AND LID APRAXIA AS INITIAL SYMPTOM OF ANTI-Ma1/Ma2-ASSOCIATED ENCEPHALITIS
Neurology, February 3, 2009; 72(5): 466 - 467.
[Full Text] [PDF]


Home page
Arch NeurolHome page
A. McKeon, J. E. Ahlskog, J. A. Britton, V. A. Lennon, and S. J. Pittock
Reversible Extralimbic Paraneoplastic Encephalopathies With Large Abnormalities on Magnetic Resonance Images
Arch Neurol, February 1, 2009; 66(2): 268 - 271.
[Abstract] [Full Text] [PDF]


Home page
BMJ Case ReportsHome page
H. Shimazaki, Y. Ando, I. Nakano, and J. Dalmau
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus
BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0720080509 - bcr0720080509.
[Abstract] [Full Text]


Home page
NEJMHome page
K. R. Daffner, J. C. Sherman, R. G. Gonzalez, and R. P. Hasserjian
Case 35-2008 -- A 65-Year-Old Man with Confusion and Memory Loss
N. Engl. J. Med., November 13, 2008; 359(20): 2155 - 2164.
[Full Text] [PDF]


Home page
BrainHome page
A. Saiz, Y. Blanco, L. Sabater, F. Gonzalez, L. Bataller, R. Casamitjana, L. Ramio-Torrenta, and F. Graus
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association
Brain, October 1, 2008; 131(10): 2553 - 2563.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Graus, A. Saiz, M. Lai, J. Bruna, F. Lopez, L. Sabater, Y. Blanco, M. J. Rey, T. Ribalta, and J. Dalmau
Neuronal surface antigen antibodies in limbic encephalitis: Clinical-immunologic associations
Neurology, September 16, 2008; 71(12): 930 - 936.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Eker, E Saka, J Dalmau, A Kurne, C Bilen, H Ozen, D Ertoy, K K Oguz, and B Elibol
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1082 - 1083.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J. Verschuuren
Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions
J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 742 - 742.
[Full Text] [PDF]


Home page
NeurologyHome page
M. E. Novillo-Lopez, J. E. Rossi, J. Dalmau, and J. Masjuan
TREATMENT-RESPONSIVE SUBACUTE LIMBIC ENCEPHALITIS AND NMDA RECEPTOR ANTIBODIES IN A MAN
Neurology, February 26, 2008; 70(9): 728 - 729.
[Full Text] [PDF]


Home page
NeurologyHome page
F. Graus and A. Saiz
Limbic encephalitis: An expanding concept
Neurology, February 12, 2008; 70(7): 500 - 501.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Jacob, S R Irani, Y A Rajabally, A Grubneac, R J Walters, M Yazaki, L Clover, and A Vincent
Hypothermia in VGKC antibody-associated limbic encephalitis
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 202 - 204.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. G. Bien, H. Urbach, J. Schramm, B. M. Soeder, A. J. Becker, R. Voltz, A. Vincent, and C. E. Elger
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy
Neurology, September 18, 2007; 69(12): 1236 - 1244.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Rajappa, R. Digumarti, S. R. Immaneni, and M. Parage
Primary Renal Lymphoma Presenting With Paraneoplastic Limbic Encephalitis
J. Clin. Oncol., August 20, 2007; 25(24): 3783 - 3785.
[Full Text] [PDF]


Home page
NeurologyHome page
W. W. Seeley, F. M. Marty, T. M. Holmes, K. Upchurch, R. J. Soiffer, J. H. Antin, L. R. Baden, and E. B. Bromfield
Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6
Neurology, July 10, 2007; 69(2): 156 - 165.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Olmos, A. Rueda, J. M. Jurado, and E. Alba
Presentation of Hodgkin's Lymphoma With Ophelia Syndrome
J. Clin. Oncol., May 1, 2007; 25(13): 1802 - 1803.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. Singh, J. H Rees, and J. W Sander
Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Bataller, K A Kleopa, G F Wu, J E Rossi, M R Rosenfeld, and J Dalmau
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 381 - 385.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. G Bien
Limbic encephalitis: extension of the diagnostic armamentarium
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 332 - 333.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S R Samarasekera, A Vincent, J L Welch, M Jackson, P Nichols, and T D Griffiths
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 391 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Shimazaki, Y Ando, I Nakano, and J Dalmau
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 324 - 325.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. Horn, M. B. Vroom, M. A. J. Tijssen, and M. J. Schultz
Two Cases of Tetanus?
J Intensive Care Med, December 1, 2006; 21(6): 364 - 368.
[Abstract] [PDF]


Home page
PNHome page
J. M Schott
Limbic encephalitis: a clinician's guide
Practical Neurology, June 1, 2006; 6(3): 143 - 153.
[Full Text] [PDF]


Home page
The OncologistHome page
J. W. de Beukelaar and P. A. S. Smitt
Managing paraneoplastic neurological disorders.
Oncologist, March 1, 2006; 11(3): 292 - 305.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
B. M. Ances, R. Vitaliani, R. A. Taylor, D. S. Liebeskind, A. Voloschin, D. J. Houghton, S. L. Galetta, M. Dichter, A. Alavi, M. R. Rosenfeld, et al.
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Brain, August 1, 2005; 128(8): 1764 - 1777.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Mihara, S Sugase, K Konaka, F Sugai, T Sato, Y Yamamoto, S Hirota, K Sakai, and S Sakoda
The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma
J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 882 - 884.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. Iseri, G. Akansel, and F. Budak
Magnetic Resonance Imaging Findings in a Patient With Bilateral Limbic Encephalitis
Arch Neurol, June 1, 2005; 62(6): 1014 - 1015.
[Full Text] [PDF]


Home page
Arch NeurolHome page
R. Scheid, T. Lincke, R. Voltz, D. Y. von Cramon, and O. Sabri
Serial 18F-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Magnetic Resonance Imaging of Paraneoplastic Limbic Encephalitis
Arch Neurol, November 1, 2004; 61(11): 1785 - 1789.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P M Candler, P E Hart, M Barnett, R Weil, and J H Rees
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom
J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1411 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P S. Smitt, C. Vedeler, J J G M Verschuuren, et al.
Recommended diagnostic criteria for paraneoplastic neurological syndromes
J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1135 - 1140.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Dalmau, F. Graus, A. Villarejo, J. B. Posner, D. Blumenthal, B. Thiessen, A. Saiz, P. Meneses, and M. R. Rosenfeld
Clinical analysis of anti-Ma2-associated encephalitis
Brain, August 1, 2004; 127(8): 1831 - 1844.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Linke, M. Schroeder, T. Helmberger, and R. Voltz
Antibody-positive paraneoplastic neurologic syndromes: Value of CT and PET for tumor diagnosis
Neurology, July 27, 2004; 63(2): 282 - 286.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Thieben, V. A. Lennon, B. F. Boeve, A. J. Aksamit, M. Keegan, and S. Vernino
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Neurology, April 13, 2004; 62(7): 1177 - 1182.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Vincent, C. Buckley, J. M. Schott, I. Baker, B.-K. Dewar, N. Detert, L. Clover, A. Parkinson, C. G. Bien, S. Omer, et al.
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis
Brain, March 1, 2004; 127(3): 701 - 712.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
E L Sampson, J D Warren, and M N Rossor
Young onset dementia
Postgrad. Med. J., March 1, 2004; 80(941): 125 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Scheid, J Honnorat, E Delmont, H Urbach, and R Biniek
A new anti-neuronal antibody in a case of paraneoplastic limbic encephalitis associated with breast cancer
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 338 - 340.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Kinirons, A. Fulton, M. Keoghan, P. Brennan, M. A. Farrell, and J. T. Moroney
Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody
Neurology, December 9, 2003; 61(11): 1623 - 1624.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
N. D. Lawn, B. F. Westmoreland, M. J. Kiely, V. A. Lennon, and S. Vernino
Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic Encephalitis
Mayo Clin. Proc., November 1, 2003; 78(11): 1363 - 1368.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Scheid, R. Voltz, T. Guthke, D. Sammler, and D. Y. von Cramon
Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis
Neurology, October 28, 2003; 61(8): 1159 - 1161.
[Full Text] [PDF]


Home page
NEJMHome page
R. B. Darnell and J. B. Posner
Paraneoplastic Syndromes Involving the Nervous System
N. Engl. J. Med., October 16, 2003; 349(16): 1543 - 1554.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Sahashi, K Sakai, K Mano, and G Hirose
Anti-Ma2 antibody related paraneoplastic limbic/brain stem encephalitis associated with breast cancer expressing Ma1, Ma2, and Ma3 mRNAs
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1332 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
J. C. Landolfi and M. Nadkarni
Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: Case study
Neuro-oncol, July 1, 2003; 5(3): 214 - 216.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
C. Thuerl, K. Muller, J. Laubenberger, B. Volk, and M. Langer
MR Imaging of Autopsy-Proved Paraneoplastic Limbic Encephalitis in Non-Hodgkin Lymphoma
AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 507 - 511.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. K. Kathula, M. Kamana, and S. Mall
Rectal Carcinoma With Dementia
Psychosomatics, February 1, 2003; 44(1): 82 - 83.
[Full Text] [PDF]


Home page
NeurologyHome page
F. Bernal, S. Shams'ili, I. Rojas, R. Sanchez-Valle, A. Saiz, J. Dalmau, J. Honnorat, P. Sillevis Smitt, and F. Graus
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease
Neurology, January 28, 2003; 60(2): 230 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Hirayama, Y Taguchi, M Sato, and T Tsukamoto
Limbic encephalitis presenting with topographical disorientation and amnesia
J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 110 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. P. Buetow and E. Eggenberger
ANNA-1--Induced Encephalitis Associated with Noninvasive Thymoma
Am. J. Roentgenol., September 1, 2002; 179(3): 802 - 803.
[Full Text] [PDF]


Home page
BrainHome page
J. H. Rees, S. F. Hain, M. R. Johnson, R. A. C. Hughes, D. C. Costa, P. J. Ell, G. Keir, and P. Rudge
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
Brain, November 1, 2001; 124(11): 2223 - 2231.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.